Natural product extracts that reduce accumulation of the Alzheimer's amyloid beta peptide: selective reduction in A beta42

Alzheimer's disease (AD) is the most common form of dementia in the elderly. Without a treatment that significantly delays the progression of the disease over 14 million Americans are likely to be affected with AD by the middle of the 21st Century, presenting an enormous economic and social bur...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of molecular neuroscience 2002-08, Vol.19 (1-2), p.129-133
Hauptverfasser:	Yager, Debra, Watson, Mona, Healy, Brent, Eckman, Elizabeth A, Eckman, Christopher B
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer Disease - metabolism Amyloid beta-Peptides - drug effects Amyloid beta-Peptides - metabolism Animals Blotting, Western Cell Survival Cells, Cultured Drug Evaluation, Preclinical Enzyme-Linked Immunosorbent Assay Humans Mice Neuroprotective Agents - pharmacology Peptide Fragments - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!